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Abstract
Glucocorticoid (GC) overexposure period as observed in Cushing’s syndrome
(CS) is associated with the metabolic syndrome and cardiovascular disease,
which persist after long-term correction of GC excess. We performed a mouse
study to identify factors that modulate metabolic recovery from a GC overexpo-
sure period. Male C57Bl/6J mice, fed a low-fat diet (LFD) or a high-fat diet
(HFD), received corticosterone (CORT) (50 lg/mL) or vehicle in the drinking
water for 4 weeks, followed by an 8-week washout period. Plasma circadian
CORT, lipids, insulin, and glucose levels were assessed regularly. Hyperinsuline-
mic-euglycemic clamp and body composition were analyzed at week 12 under
anesthesia. CORT treatment increased plasma CORT levels, food intake, and
plasma insulin and lipid levels on both diets. CORT treatment abrogation
normalized CORT levels, food intake, and body weight, whereas plasma insulin
levels remained significantly higher in CORT-treated mice on both diets. Only on
a HFD, CORT-treated mice had decreased lean body mass and higher fat mass. In
conclusion, CORT excess period induces long-lasting metabolic changes and
some are present only on a HFD. These observations indicate that diet-dependent
CORT effects might contribute to the adverse cardiovascular risk profile observed
in CS patients, and possibly also in subjects exposed to chronic stress.
Introduction
In humans, prolonged excessive exposure to glucocortic-
oids (GC) as seen in Cushing’s syndrome (CS) is associated
with an increased incidence of the metabolic syndrome
(MetS), a clustering of cardiovascular risk factors such as
increased blood pressure, dyslipidemia, and insulin resis-
tance, and increased cardiovascular morbidity and mortal-
ity (Newell-Price et al. 2006). Increased GC exposure
changes eating behavior and food preferences facilitating
the development of obesity and the MetS (Dallman et al.
2003; Warne et al. 2009). Intriguingly, patients with CS
remain at increased cardiovascular risk, even despite long-
term successful correction of GC excess (Dekkers et al.
2007). However, the causal relation between the episode of
cortisol overexposure and long-term changes in the cardio-
vascular risk factors is not established and the modifiers of
normalization are unknown and are difficult to assess in
humans because of the rarity and heterogeneity of CS.
Representative animal models that enable to study the
metabolic effects of corticosterone (CORT) overexposure
are limited. Whereas in humans, GCs induce weight gain
and increase appetite (Chandola et al. 2006), in rats high
CORT concentrations (using either chronic stressors or via
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implantation of subcutaneous [sc] CORT pellets or intra-
peritoneal [ip] injections) decrease intake of standard chow
(Bell et al. 2000). These catabolic effects of GC can be
counteracted by adding 30% sucrose to regular chow of
CORT-treated rats, and diet (e.g., the addition of sucrose
to chow) in fact appears to be a crucial factor for the devel-
opment of obesity in rats exposed to high CORT. Indeed,
when CORT-treated rats with sc pellets were given regular
chow with the addition of sucrose, they not only developed
visceral obesity but also became markedly hyperinsulinemic
and hypercholesterolemic (Bell et al. 2000; Christ-Crain
et al. 2008).
Chronic oral CORT supplementation was recently
reported to induce impressive metabolic changes in mice
including weight gain, increased adiposity, elevated plasma,
insulin and triglyceride levels, and hyperphagia (Karatso-
reos et al. 2010). As these features resemble the changes
observed in individuals suffering from MetS, this represents
a model for hypercortisolemia and stress-related obesity.
In the present study, we hypothesized that a period of
overexposure to GC in mice would result in long-term or
even permanent metabolic changes, and that this would
be affected by the composition of the diet. We show that
8 weeks after overexposure to GC, plasma insulin levels
remained significantly higher both on low-fat diet (LFD)
as well as on high-fat diet (HFD). Furthermore, we show
that overexposure to GC persistently altered body compo-
sition, but only in the presence of a HFD.
Materials and Methods
Animals
Eight-week-old male C57Bl/6J mice (Charles River, Maas-
tricht, The Netherlands) were single housed in a separate
room from other experimental animals in the facility to
minimize environmental stressors, and maintained on a
12 h:12 h light-dark cycle (lights on 7 A.M.), with ad libi-
tum access to food and drinking water. All animal experi-
ments were performed in accordance with the regulations
of Dutch law on animal welfare and the institutional eth-
ics committee for animal procedures from the Leiden
University Medical Center approved the protocol.
Experiment 1 (LFD experiment)
C57Bl/6J mice (n = 20) were fed a LFD (10% kcal% fat,
D12451B, Research Diet Services, Inc., New Brunswick,
NJ) and after 4 weeks (at 12 weeks of age), they were
matched for body weight, the levels of plasma triglyce-
rides, nonesterified free fatty acids, and cholesterol, and
randomized to receive either 50 lg/mL CORT (Sigma-
Aldrich, Manchester, U.K.) in the drinking water (CORT
group, n = 10) (containing 0.25% ethanol as vehicle), or
0.25% ethanol as vehicle only in the drinking water (con-
trol group, n = 10), for 4 weeks. At week 12, dual energy
X-ray absorptiometry (DEXA) analysis was performed to
determine body composition. Hyperinsulinemic-euglyce-
mic clamp analysis was performed to determine insulin
sensitivity (control group n = 10, CORT group n = 10).
Experiment 2 (HFD experiment)
C57Bl/6J mice (n = 20) were fed a HFD (45% kcal% fat,
D12451, Research Diet Services, Inc., New Brunswick, NJ)
from 8 weeks of age and after reaching 12 weeks of age,
were matched for weight, plasma triglycerides, nonesteri-
fied free fatty acids, and cholesterol, and randomized to
receive either 50 lg/mL CORT (Sigma-Aldrich) in the
drinking water (CORT group, n = 10) (containing 0.25%
ethanol as vehicle), or to drinking water with 0.25% etha-
nol as vehicle only (control group, n = 10), for 4 weeks. At
week 12, DEXA analysis was performed to determine body
composition. Hyperinsulinemic-euglycemic clamp analysis
was performed to determine the insulin sensitivity in a sub-
set of mice (control group n = 6, CORT group n = 6).
Circadian sampling of plasma levels
Blood for analysis of plasma CORT levels was sampled in
both experiments at baseline, and at weeks 4, 8, and 12
during the first light hour at 0700 h, at 1200 h, during
the last light hour at 1800 h, and at 2200 h (3 h after the
onset of the dark phase). During the dark phase, samples
were collected in red light conditions. All CORT samples
were obtained within 90 sec from disturbing the cage, via
tail incision, allowing the mouse to move freely on top of
the home cage (Dalm et al. 2008). Plasma insulin, glu-
cose, total cholesterol, triglycerides, and nonesterified free
fatty acids were sampled after overnight fast at baseline,
weeks 4, 8, and 12. Body weight, food intake, and water
intake were measured weekly.
DEXA scan
Body composition was measured at week 12 by DEXA
using the Norland pDEXA Sabre X-Ray Bone Densitome-
ter (Norland, Hampshire, U.K.). Before measuring, mice
were anesthetized with a combination of 6.25 mg/kg ace-
promazine (Alfasan, Woerden, the Netherlands), 6.25 mg/
kg midazolam (Roche, Mijdrecht, the Netherlands), and
0.31 mg/kg fentanyl (Janssen-Cilag, Tilburg, the Nether-
lands). Mice were scanned in toto, and the heads were
subsequently excluded from the analysis due to the inabil-
ity of the DEXA scan to accurately determine the compo-
sition of the tissue underneath the skull.
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Hyperinsulinemic-euglycemic clamp
Hyperinsulinemic-euglycemic clamp studies were per-
formed at week 12 in postabsorptive (i.e., overnight
fasted) condition. Mice were anesthetized with 6.25 mg/
kg acepromazine (Alfasan, Woerden, the Netherlands),
6.25 mg/kg midazolam (Roche, Mijdrecht, the Nether-
lands), and 0.31 mg/kg fentanyl (Janssen-Cilag, Tilburg,
the Netherlands). First, the basal rate of glucose turnover
was determined by giving a primed (0.5 lCi) continuous
(0.9 lCi/h) intravenous (iv) infusion of D-[3-3H]-glucose
(37 MBq) (GE Healthcare, Little Chalfont, U.K.) for
60 min. Subsequently, insulin (Novo Nordisk, Bagsværd,
Denmark) was administered in a primed (3.7 mU) con-
tinuous 6.1 mU/h for LFD-fed mice and 11.25 mU/h for
HFD-fed mice as iv infusion for 90 min to attain steady-
state circulating insulin levels. Every 10 min, the plasma
glucose concentration was determined via tail vein bleed-
ing (<3 lL) (Accu-chek, Sensor Comfort; Roche Diagnos-
tics GmbH, Mannheim, Germany) and the iv infusion
rate of a 12.5% D-glucose solution was adjusted to main-
tain euglycemia. Blood samples (60 lL) were taken dur-
ing the basal period (after 50 and 60 min) and during the
hyperinsulinemic period (after 70, 80, and 90 min) to
determine plasma concentrations of glucose, insulin, and
specific activity of 3H-glucose. The mice were sacrificed at
the end of the clamp.
Plasma analysis
Plasma CORT levels were determined by radioimmunoas-
say (MP Biomedicals LCC, Orangeburg, NY). Plasma lev-
els of total cholesterol, triglycerides, and nonesterified free
fatty acids were measured with enzymatic colorimetric
reaction (Roche diagnostics GmbH, Mannheim; and
Wako Pure Chemical Industries, respectively), plasma
insulin was measured with an ELISA (Crystal Chem Inc.,
Downers Grove, IL), and plasma glucose with a hexoki-
nase method (Instruchemie, Delfzijl, The Netherlands).
Homeostasis model index of insulin (HOMA-IR) was cal-
culated by multiplying fasting insulin concentration (lU/
mL) with fasting glucose (mmol/L), and dividing with
22.5 (Mather 2009).
Calculations and statistical analysis
Data from the hyperinsulinemic-euglycemic clamp studies
were calculated as previously described by Voshol et al.
(2001). The rate of glucose uptake (lmol/min per kilo-
gram) was calculated in the basal period as well as during
the steady-state hyperinsulinemia (70, 80, and 90 min of
the clamp) as the rate of tracer infusion (dpm/min) divided
by the plasma-specific activity of 3H-glucose (dpm/lmol)
in the plasma. Endogenous glucose production (lmol/min
per kilogram) was calculated as the difference between the
tracer-derived rate of glucose uptake and the glucose infu-
sion rate. Glucose uptake as well as glucose production was
corrected for body weight.
Data are presented as means  SD. Statistical differences
were calculated using Mann–Whitney test for nonparamet-
ric data, with GraphPad Prism, version 5.01 (La Jolla, CA).
P < 0.05 was considered statistically significant.
Results
Pilot experiment for the determination of
optimal CORT dose
Prior to both experiments, we performed a dose-finding
study in mice fed a HFD with 12.5 lg/mL (n = 2),
25 lg/mL (n = 4), and 50 lg/mL (n = 2) of CORT and
control receiving 0.25% ethanol (n = 2) as vehicle for
4 weeks to determine the optimal CORT dose. These dos-
ages were chosen based upon a previous study that docu-
mented profound metabolic effects with CORT 100 lg/
mL and less pronounced effects with 25 lg/mL (Karatso-
reos et al. 2010). Based upon our dose-finding study, we
chose 50 lg/mL CORT in the drinking water for our sub-
sequent experiments as this dose led to the most pro-
found increases in food intake and body weight as well as
in plasma cholesterol (data not shown).
CORT treatment increases plasma CORT
concentrations and affects circadian rhythm
of CORT
A circadian rhythm of CORT was present at baseline in
both dietary conditions (Fig. 1A and E) and chronic high
doses of CORT (50 lg/mL) increased plasma CORT levels
and affected circadian rhythm (Fig. 1B and F, respec-
tively). At week 8 (4 weeks after abrogation of CORT), in
the LFD experiment CORT-treated animals had recovered
and were not different from the controls, whereas in the
HFD experiment, the peak (1800 h) circadian (endoge-
nous) CORT concentrations were 22% lower in CORT-
treated animals compared to controls (Fig. 1C and G,
respectively). At week 12, circadian CORT levels were
equal to the controls (Fig. 1D and H).
CORT treatment induces transient changes
in food intake and body weight
LFD experiment
CORT treatment increased food intake (by 14% vs. con-
trols at week 1 and 27% at week 4) (Fig. 2C). After
ª 2013 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
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removal of CORT, food intake rapidly decreased by
29% versus controls returning to the level of the
control group at week 6. This increase in food intake
was not translated into an increase in body
weight, being comparable between the groups during
the CORT treatment. Removal of CORT transiently
decreased body weight in the CORT group at weeks 5
and 6 (by 5%, and 4%, respectively), but body
weight was not different from controls thereafter
(Fig. 2A). CORT treatment increased water intake (with
CORT in it) up to 3-fold during the treatment period
and decreased close to the level of the controls after
removal of CORT from the drinking water, however,
still remaining significantly higher to the end of the
experiment (Fig. 2E).
HFD experiment
CORT treatment increased food intake by +19% versus
controls after the first week (Fig. 2D), with a concomitant
increase in body weight that was significant at week 3 and
remained significantly higher at weeks 4 and 5 (+11%,
+19%, and +9%, respectively) (Fig. 2B) when compared to
the controls. After removal of CORT, food intake normal-
ized at week 6, and did not differ from controls for the
remainder of the experiment. CORT treatment did not
affect water intake except after removal of CORT from the
drinking water at weeks 5 and 10 (by 21% and 10%,
respectively) when water intake was significantly lower in
the CORT-treated group when compared to controls
(Fig. 2F).
CORT treatment induces transient changes
in plasma lipids
CORT treatment increased plasma levels of triglycerides
and nonesterified free fatty acids significantly in the LFD
experiment at week 4 (by +56% and +24%, respectively)
(Table 1). In the HFD experiment, additionally, signifi-
cant increases versus controls were observed in the plasma
levels of total cholesterol and nonesterified free fatty acids
at week 4 (+38% and +21%, respectively) (Table 1). At
week 8, plasma triglycerides levels were significantly
higher in the HFD group (+21% vs. controls) (Table 1).
Insulin and HOMA-IR are increased long
term by CORT treatment
As expected, when compared to controls, CORT treat-
ment significantly increased plasma insulin concentrations
on both diets (LFD: 8-fold and HFD: 3-fold increase at
week 4) (Table 1), and remained significantly higher after
removal of CORT treatment. Of note, insulin levels did
not markedly decrease in CORT-treated animals between
week 8 (LFD: +83% and HFD: +67%) and week 12 (LFD:
+67% and HFD: +69%) (Table 1). Plasma glucose was
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Figure 1. Effect of CORT treatment on circadian plasma CORT of mice fed a low-fat diet (A–D) (control group: open bars, CORT group: light
gray bars) or high-fat diet (E–H) (control group: dark gray bars, CORT group: black bars) at baseline, week 4, week 8, and week 12,
Mann–Whitney test, *P < 0.05, ***P < 0.001.
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significantly decreased in the LFD experiment at weeks 8
and 12 (14% and 17%, respectively) and by 21% in
the HFD experiment at week 4 in the CORT groups
(Table 1). Changes in plasma insulin and glucose induced
by CORT treatment, suggested decreased insulin sensitiv-
ity as reflected in HOMA-IR. In both experiments, CORT
significantly increased HOMA-IR at week 4 (LFD: 8-fold
and HFD: 3-fold) (Table 1). Furthermore, HOMA-IR at
week 8 was still significantly increased by +69% in the
HFD experiment after CORT treatment (Table 1), and by
+45% in the LFD experiment at week 12, which, however,
did not reach significance, (Table 1) when compared to
the controls (Table 1).
CORT treatment induces long-lasting
changes in body composition only in the
presence of HFD
In the LFD experiment, no long-lasting changes in
body composition were observed (Fig. 3A and B). In the
HFD experiment, after 12 weeks, CORT treatment sig-
nificantly reduced lean body mass (23  3% vs.
28  4% of total body weight, CORT vs. controls,
respectively) (Fig. 3C), and significantly increased fat
mass (55  5% vs. 64  7% of the total body weight)
(Fig. 3D).
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CORT treatment does not affect endogenous
glucose production or glucose disposal in
the long term
Endogenous glucose production and glucose disposal, as
derived from the hyperinsulinemic-euglycemic clamp stud-
ies, were not different between the CORT-treated and the
control group in the LFD experiment (Fig. 4A and B), nor
in the HFD experiment (Fig. 4C and D) at week 12.
Discussion
We demonstrated that a period of overexposure to GCs
induces long-lasting, potentially permanent, changes in
metabolic parameters, but only in the presence of a HFD.
In HFD-fed animals, increased insulin levels and altered
body composition did not normalize even after an 8-week
washout period, when parameters like food intake and
body weight had returned to control levels for about
6 weeks.
As anticipated, in our study, high CORT levels
increased food intake and induced metabolic changes that
resemble the MetS, like an increase in plasma insulin lev-
els, lipids, and HOMA index, irrespective of a HFD or
LFD. While some effects were reversible after normaliza-
tion of CORT levels, insulin was irreversibly increased
under both LFD and HFD conditions. Mice on HFD
showed additional long-lasting effects of high CORT
exposure, that is, adversely affected body composition
(even if body weight quickly normalized after cessation of
CORT exposure). This indicates that HFD aggravates the
adverse long-term metabolic effects of transient high
CORT exposure. This points to a crucial role for dietary
composition in the development of the MetS in condi-
tions with periodic excessive CORT exposure.
Supraphysiological CORT levels were readily induced
using oral CORT in the drinking water. This treatment
with CORT also affected circadian CORT rhythm, impair-
ing the degree of variations in plasma concentrations.
After discontinuation of CORT treatment, circadian
rhythm gradually returned to the level of the controls at
week 12, although evening (1800 h) CORT peak was still
decreased at week 8 in the HFD experiment. This indi-
cates that incomplete recovery of the HPA axis after a
period of exogenous supraphysiological CORT supple-
mentation, as has been documented extensively in
humans both after treatment for CS (Pereira et al. 2003)
and in patients previously exposed to exogenous supra-
physiological GCs (Lamberts et al. 1997), might be
dependent on the composition of the diet.
CORT treatment increased food intake on both diets,
but body weight increased only on HFD. It has been pre-
viously shown that high CORT levels stimulate voluntaryTa
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food intake dose dependently (Bell et al. 2000; Bhatnagar
et al. 2000; la Fleur et al. 2004). In addition, in case of
different food availability, food preference changes toward
more energy-rich “palatable” food (Pecoraro et al. 2004)
serving the evolutionary purpose to attain the most effi-
cient fuels to counteract the adverse changes in insulin
sensitivity that occur during stress (Dallman et al. 2003).
With increasing insulin and GC levels, food intake is even
stimulated in the presence of less palatable foods (Akana
et al. 1985; Strack et al. 1995; Bell et al. 2000). In agree-
ment, in the present experiments with LFD and HFD, the
increased plasma CORT levels were accompanied by
increases in circulating insulin, triglycerides, cholesterol,
and free fatty acid levels. The increased food intake
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Figure 4. Effect of CORT treatment on endogenous glucose production and glucose disposal during basal period of glucose infusion (basal)
and hyperinsulinemia (hyper) in mice fed a low-fat diet (A and B) (control group: open bars, CORT group: light gray bars) or high-fat diet
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resulted in increased body weight only on HFD, suggest-
ing that the increase in food intake on LFD was just suffi-
cient to compensate for the catabolic effects of increased
CORT levels. However, higher dosages of CORT than the
one used in our study were able to increase body weight
on regular chow diet (Karatsoreos et al. 2010). Intrigu-
ingly, the increase in fat mass remains present even after
a washout from the increased plasma CORT levels.
Water intake and therefore CORT intake were
increased only in the LFD but not in the HFD experiment
in the CORT-treated group. However, even when con-
suming a higher amount of CORT during LFD, the
reversibility of the metabolic changes after LFD (but not
after HFD) was complete, which strengthens our conclu-
sions on the modulatory role of the diets per se.
Although body weight returned to that of the controls
after discontinuation of CORT treatment, on HFD the
increase in plasma triglycerides was still present at week
8, and insulin concentrations remained elevated relative
to controls in both diet groups even at week 12. However,
endogenous glucose production and disposal assessed
with hyperinsulinemic-euglycemic clamps at the end of
the study did not indicate reduced insulin sensitivity.
Whereas the effects on body weight were transient,
long-lasting changes in body composition were found on
HFD, where reduced lean body mass and increased fat
mass were observed even after 12 experimental weeks.
These effects of CORT treatment on body composition
were not observed in the LFD experiment. Chronically
administered GCs facilitate muscle atrophy (Watson et al.
2012) and increase visceral fat mass in mice (Gounarides
et al. 2008; Karatsoreos et al. 2010). In the human, the
equivalent of chronic high GC is CS, a rare clinical syn-
drome where patients are exposed to increased adrenal
cortisol secretion due to an ACTH-producing pituitary or
ectopic tumor or due to an adrenal adenoma (Newell-
Price et al. 2006). Patients with CS have increased preva-
lence of the MetS (Arnaldi et al. 2003; van Raalte et al.
2009), but intriguingly, after 1 year of remission still have
increased waist circumference (Faggiano et al. 2003; Gi-
ordano et al. 2011) and even after long-term remission
higher visceral fat mass was observed without affecting
body mass index (Barahona et al. 2009).
The fact that the long-lasting changes observed in mice
after a period of exposure to high CORT persist for a
longer period of time in the presence of HFD is intrigu-
ing in view of the incomplete reversibility of metabolic
changes observed in patients with CS after correction for
hypercortisolism. Humans exposed to stress levels of GC,
like in CS, will direct their food preference toward highly
palatable foods, in agreement with the biological effects of
GC, thereby aggravating the adverse cardiometabolic
effects and thus facilitating the development and persis-
tence of MetS. Epidemiological data also indicate an
increased prevalence of the MetS in conditions associated
with alterations in the HPA axis, like in anxiety and
depression, after medical treatment with GC, and also in
sleep disorders (Balbo et al. 2010; Sahar and Sassone-
Corsi 2012). As it appears that these diet-dependent
effects of CORT during stress strongly facilitate the persis-
tent adverse cardiovascular risk profile, the interactions
between the availability of “fast food” and every-day-
stress are novel features to be accentuated in future stud-
ies on cardiovascular morbidity and mortality.
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